Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature

References

• French CA, Ramirez CL, Kolmakova J, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 2008;27(15):2237-42
   PubMed Web of Science ®Google Scholar
• Suzuki S, Kurabe N, Ohnishi I, et al. NSD3-NUT-expressing midline carcinoma of the lung: First characterization of primary cancer tissue. Pathol Res Pract 2015;211(5):404-8
   PubMed Web of Science ®Google Scholar
• Kees UR, Mulcahy MT, Willoughby ML. Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatr Hematol Oncol 1991;13(4):459-64
   PubMedGoogle Scholar
• Kubonishi I, Takehara N, Iwata J, et al. Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res 1991;51:3327-8
   PubMed Web of Science ®Google Scholar
• Marx A, French CA, Fletcher JA. Carcinoma with t(15;19) translocation. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harriss CC, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. IARC Press; Lyon, France: 2004. 185-6
   Google Scholar
• Stelow EB. A review of NUT midline carcinoma. Head Neck Pathol 2011;5(1):31-5
   PubMedGoogle Scholar
• Bauer D, Mitchell CM, Strait KM, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 2012;18(20):5773-9
   PubMed Web of Science ®Google Scholar
• Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 2009;33(7):984-91
   PubMed Web of Science ®Google Scholar
• French CA. Pathogenesis of NUT Midline Carcinoma. Annu Rev Pathol 2012;7:247-65
   PubMed Web of Science ®Google Scholar
• Joey schwartz is an NMC patient and participant in the International NMC registry. Available from: www.nmcregistry.org/
   Google Scholar
• French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004;22(20):4135-9
   PubMed Web of Science ®Google Scholar
• Mertens F, Wiebe T, Adlercreutz C, et al. Successful treatment of a child with t(15;19)-positive tumor. Pediatr Blood Cancer 2007;49(7):1015-17
   PubMed Web of Science ®Google Scholar
• Shehata BM, Steelman CK, Abramowsky CR, et al. NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary. Pediatr Dev Pathol 2010;13(6):481-5
   PubMed Web of Science ®Google Scholar
• Tanaka M, Kato K, Gomi K, et al. NUT Midline Carcinoma: Report of 2 Cases Suggestive of Pulmonary Origin. Am J Surg Pathol 2012;36(3):381-8
   PubMed Web of Science ®Google Scholar
• Yan J, Diaz J, Jiao J, et al. Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma. J Biol Chem 2011;286(31):27663-75
   PubMed Web of Science ®Google Scholar
• Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol 2008;32(6):828-34
   PubMed Web of Science ®Google Scholar
• Evans AG, French CA, Cameron MJ, et al. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol 2012;36(8):1222-7
   PubMed Web of Science ®Google Scholar
• Wartchow EP, Moore TS, French CA, Mierau GW. Ultrastructural features of NUT midline carcinoma. Ultrastruct Pathol 2012;36(4):280-4
   PubMed Web of Science ®Google Scholar
• Bishop JA, Westra WH. NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol 2012;36(8):1216-21
   PubMed Web of Science ®Google Scholar
• Zhu B, Laskin W, Chen Y, et al. NUT midline carcinoma: a neoplasm with diagnostic challenges in cytology. Cytopathology 2011;22(6):414-17
   PubMed Web of Science ®Google Scholar
• den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, et al. NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol 2009;33(8):1253-8
   PubMed Web of Science ®Google Scholar
• Davis BN, Karabakhtsian RG, Pettigrew AL, et al. Nuclear protein in testis midline carcinoma. Arch Pathol Lab Med 2011;135:1494-8
   PubMed Web of Science ®Google Scholar
• Ziai J, French CA, Zambrano E. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland. Head and Neck Pathol 2010;4:163-8
   PubMedGoogle Scholar
• Hsieh MS, French CA, Liang CW, Hsiao CH. NUT Midline carcinoma: Case Report and Review of the Literature. Int J Surg Pathol 2011;19(6):808-12
   PubMed Web of Science ®Google Scholar
• Fang W, French CA, Cameron MJ, et al. Clinicopathologic significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Int J Surg Pathol 2012;18(20):5773-9
   Google Scholar
• Rutt AL, Poulik J, Siddiqui AH, et al. NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl. Ann Otol Rhinol Laryngol 2011;120(8):546-9
   PubMed Web of Science ®Google Scholar
• Engleson J, Soller M, Panagopoulos I, et al. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy. BMC Cancer 2006;6:69
   PubMed Web of Science ®Google Scholar
• Teo M, Crotty P, O’Sullivan M, et al. NUT midline carcinoma in a young woman. J Clin Oncol 2011;29(12):e336-9
   Google Scholar
• Dang TP, Gazdar AF, Virmani AK, et al. Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst 2000;92(16):1355-7
   PubMed Web of Science ®Google Scholar
• Bhaijee F, Pepper DJ, Pitman KT, Bell D. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma. Ann Diagn Pathol 2011;15(1):69-77
   PubMed Web of Science ®Google Scholar
• Bellizzi AM, Bruzzi C, French CA, Stelow EB. The cytologic features of NUT midline carcinoma. Cancer 2009;117(6):508-15
   PubMed Web of Science ®Google Scholar
• Schwartz BE, Hofer MD, Lemieux ME, et al. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res 2011;71(7):2686-96
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature 2010;468(7327):1067-73
   PubMed Web of Science ®Google Scholar
• Schwartz BE, Hofer MD, Lemieux ME, et al. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res 2011;71(7):2686-96
   PubMed Web of Science ®Google Scholar
• Lee AC, Kwong YI, Fu KH, et al. Disseminated mediastinal carcinoma with chromosomal translocation (15;19). A distinctive clinicopathologic syndrome. Cancer 1993;72(7):2273-6
   PubMed Web of Science ®Google Scholar
• French CA. Demystified molecular pathology of NUT midline carcinomas. J Clin Pathol 2010;63(6):492-6
   PubMed Web of Science ®Google Scholar
• Nicole Grace Chau, Mitchell CM, Aserlind A, et al. Bradner, Christopher Alexander French. Aggressive treatment and survival outcomes in NUT midline carcinoma (NMC) of the head and neck (HN). J Clin Oncol 2014;32(suppl; abstr 6057):5s
   Google Scholar
• Schwartz BE, Hofer MD, Lemieux ME, et al. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res 2011;71:2686
   PubMed Web of Science ®Google Scholar
• Maher OM, Christensen AM, Yedururi S, et al. Histone deacetylase inhibitor for NUT midline carcinoma. Pediatr Blood Cancer 2015;62:715-17
   PubMed Web of Science ®Google Scholar
• Open label, multi-center study to assess the safety, tolerability and pharmacokinetics of CUDC-907 in subjects with advanced/relapsed solid tumors. Available from: https://clinicaltrials.gov/ct2/show/NCT02307240
   Google Scholar
• Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature 2010;468(7327):1067-73
   PubMed Web of Science ®Google Scholar
• A study to investigate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of GSK525762 in subjects with NUT midline carcinoma (NMC) and other cancers. Available from: https://clinicaltrials.gov/ct2/show/NCT01587703
   Google Scholar
• A phase IB trial with OTX015, a small molecule inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients with selected advanced solid tumors. Available from: https://clinicaltrials.gov/ct2/show/NCT02259114
   Google Scholar
• BAY1238097, First in man. Available rrom https://clinicaltrials.gov/ct2/show/NCT02369029
   Google Scholar
• A two part, multicenter, open-label study of TEN-010 given subcutaneously. Available from: https://clinicaltrials.gov/ct2/show/NCT01987362
   Google Scholar
• Mills AF, Lanfranchi M, Wein RO, et al. NUT midline carcinoma: a case report with a novel translocation and review of the literature. Head Neck Pathol 2013;8(2):182-6
   PubMedGoogle Scholar
• Zhou S, Shamszadeh M, Tovar JP, et al. NUT midline carcinoma in a pediatric patient with an unusual clinical and histologic presentation. Arch Pathol Lab Med 2012;136(9):1086
   Web of Science ®Google Scholar
• Taniyama TK, Nokihara H, Tsuta K, et al. Clinicopathological features in young patients treated for small-cell lung cancer: Significance of immunohistological and molecular analyses. Clin Lung Cancer 2014;15(3):244-7
   PubMed Web of Science ®Google Scholar
• Young MR, Millington K, Clarke LE, Helm K. NUT midline carcinoma with cutaneous metastases. J Am Acad Dermatol 2012;67(2):323-4
   PubMed Web of Science ®Google Scholar